Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srikanth Talluri

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Blood|March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple MyelomaChandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.
Cancer Discovery|April 18, 2014
Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidyCourtney H Coschi, Charles A Ishak, David Gallo, et al.
Blood Cancer Journal|July 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myelomaXueping Wan, Ting Du, Teng Fang, et al.
Blood Cancer Journal|February 3, 2023
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeuticsDaisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2025
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple MyelomaAnil Aktas Samur, Jill Corre, Srikanth Talluri, et al.
Molecular and Cellular Biology|March 26, 2014
A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene-targeted miceMatthew J Cecchini, Michael J Thwaites, Srikanth Talluri, et al.
Gastroenterology|May 13, 2023
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal AdenocarcinomaSubodh Kumar, Jiangning Zhao, Srikanth Talluri, et al.
Blood Cancer Discovery|September 27, 2021
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activationAnnamaria Gulla, Eugenio Morelli, Mehmet K Samur, et al.
Molecular and Cellular Biology|April 9, 2014
Loss of the mammalian DREAM complex deregulates chondrocyte proliferationChantal Forristal, Shauna A Henley, James I MacDonald, et al.
Blood|June 4, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple MyelomaAnaïs Schavgoulidze, Jian Cui, Jessica Encinas, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Blood|March 16, 2025
Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple MyelomaChandraditya Chakraborty, Srikanth Talluri, Moritz Binder, et al.
Cancer Discovery|April 18, 2014
Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidyCourtney H Coschi, Charles A Ishak, David Gallo, et al.
Blood Cancer Journal|July 15, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myelomaXueping Wan, Ting Du, Teng Fang, et al.
Blood Cancer Journal|February 3, 2023
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeuticsDaisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2025
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple MyelomaAnil Aktas Samur, Jill Corre, Srikanth Talluri, et al.
Molecular and Cellular Biology|March 26, 2014
A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene-targeted miceMatthew J Cecchini, Michael J Thwaites, Srikanth Talluri, et al.
Gastroenterology|May 13, 2023
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal AdenocarcinomaSubodh Kumar, Jiangning Zhao, Srikanth Talluri, et al.
Blood Cancer Discovery|September 27, 2021
Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activationAnnamaria Gulla, Eugenio Morelli, Mehmet K Samur, et al.
Molecular and Cellular Biology|April 9, 2014
Loss of the mammalian DREAM complex deregulates chondrocyte proliferationChantal Forristal, Shauna A Henley, James I MacDonald, et al.
Blood|June 4, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple MyelomaAnaïs Schavgoulidze, Jian Cui, Jessica Encinas, et al.
Pageof 5